The objective of the research is to develop technology that will facilitate the regeneration of heart, lung, and other cell types from somatic stem cells. Although multipotent cells are known to reside within numerous adult tissues, their limited proliferative and differentiative capacities constrain their use for regenerative therapies. Prospects for improving efficacy of contribution to target tissue will be facilitated by molecular genetic-level knowledge of the factors that regulate differentiation. To date, differentiation of somatic stem cells has been evaluated primarily in whole animal models of tissue damage. Since whole animal models are not readily conducive for the discovery of genes and proteins that regulate differentiation, this application proposes four aims to design and use in vitro, culture assays to identify molecular regulators of somatic stem cell differentiation. Emphasis will be placed on, but not limited, to cardiomyocyte differentiation. The first two aims will design culture assays to evaluate differentiation of a promising somatic stem cell population (known as SP cells) that can be FACS enriched from a range of differentiated tissues, including heart.
Aim 1 will evaluate whether factors and tissues that promote embryonic cardiomyogenesis stimulate these cells to differentiate. Preliminary data describe interspecies tissue recombination assays to evaluate differentiation in vitro. Similarly, aim 2 will test the hypothesis that differentiated myocardium provides factors that promote differentation.
Aims 3 and 4 are to design moderate to high throughput assays for the identification of synthetic and natural modulators of differentiation.
Aim 3 will define molecular markers of the somatic stem cell to cardiomyocyte differentiation process that will be used as endpoints in these assays.
Aim 4 will establish the mechanics of small molecule screens and carry out pilot screens. To carry out Aim 4 concurrently with the other aims, embryonic stem cells will be used initially as they proliferate well in culture and differentiate into cardiomyocytes in response to known inducers (preliminary data).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21HL071913-02
Application #
6665296
Study Section
Special Emphasis Panel (ZHL1-CSR-O (S1))
Program Officer
Lundberg, Martha
Project Start
2002-09-30
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
2
Fiscal Year
2003
Total Cost
$288,000
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kiselyuk, Alice; Farber-Katz, Suzette; Cohen, Tom et al. (2010) Phenothiazine neuroleptics signal to the human insulin promoter as revealed by a novel high-throughput screen. J Biomol Screen 15:663-70
Bushway, Paul J; Azimi, Behrad; Heynen-Genel, Susanne et al. (2010) Hybrid median filter background estimator for correcting distortions in microtiter plate data. Assay Drug Dev Technol 8:238-50
Bushway, Paul J; Mercola, Mark; Price, Jeffrey H (2008) A comparative analysis of standard microtiter plate reading versus imaging in cellular assays. Assay Drug Dev Technol 6:557-67
Foley, Ann C; Korol, Oksana; Timmer, Anjuli M et al. (2007) Multiple functions of Cerberus cooperate to induce heart downstream of Nodal. Dev Biol 303:57-65
Bushway, Paul J; Mercola, Mark (2006) High-throughput screening for modulators of stem cell differentiation. Methods Enzymol 414:300-16
Wei, Zhi-Liang; Petukhov, Pavel A; Bizik, Fero et al. (2004) Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation. J Am Chem Soc 126:16714-5